Correlation Between Zura Bio and Editas Medicine

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Zura Bio and Editas Medicine at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Zura Bio and Editas Medicine into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Zura Bio Limited and Editas Medicine, you can compare the effects of market volatilities on Zura Bio and Editas Medicine and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Zura Bio with a short position of Editas Medicine. Check out your portfolio center. Please also check ongoing floating volatility patterns of Zura Bio and Editas Medicine.

Diversification Opportunities for Zura Bio and Editas Medicine

0.89
  Correlation Coefficient

Very poor diversification

The 3 months correlation between Zura and Editas is 0.89. Overlapping area represents the amount of risk that can be diversified away by holding Zura Bio Limited and Editas Medicine in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Editas Medicine and Zura Bio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Zura Bio Limited are associated (or correlated) with Editas Medicine. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Editas Medicine has no effect on the direction of Zura Bio i.e., Zura Bio and Editas Medicine go up and down completely randomly.

Pair Corralation between Zura Bio and Editas Medicine

Given the investment horizon of 90 days Zura Bio Limited is expected to under-perform the Editas Medicine. But the stock apears to be less risky and, when comparing its historical volatility, Zura Bio Limited is 1.03 times less risky than Editas Medicine. The stock trades about -0.11 of its potential returns per unit of risk. The Editas Medicine is currently generating about 0.14 of returns per unit of risk over similar time horizon. If you would invest  122.00  in Editas Medicine on November 18, 2024 and sell it today you would earn a total of  16.00  from holding Editas Medicine or generate 13.11% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy100.0%
ValuesDaily Returns

Zura Bio Limited  vs.  Editas Medicine

 Performance 
       Timeline  
Zura Bio Limited 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Zura Bio Limited has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in March 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
Editas Medicine 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Editas Medicine has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's forward indicators remain comparatively stable which may send shares a bit higher in March 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Zura Bio and Editas Medicine Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Zura Bio and Editas Medicine

The main advantage of trading using opposite Zura Bio and Editas Medicine positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Zura Bio position performs unexpectedly, Editas Medicine can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Editas Medicine will offset losses from the drop in Editas Medicine's long position.
The idea behind Zura Bio Limited and Editas Medicine pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.

Other Complementary Tools

Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets